Moderna MRNA
NASDAQ MRNA
$143.97 +7.35 (+5.38%)
As of: Sep 11, 2026 · 3:59 PM EDT

Moderna (MRNA) Tax Rate (QoQ) (2019 - 2026)

Analysis

Moderna (MRNA) Tax Rate (QoQ) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -128.00
Mar 31, 2026 270.00
Dec 31, 2025 357.00
Sep 30, 2025 -610.00
Jun 30, 2025 -13.00
Mar 31, 2025 -613.00
Dec 31, 2024 -3,269.00
Mar 31, 2024 20,914.00
Dec 31, 2023 -12,461.00
Sep 30, 2023 -10,649.00
Jun 30, 2023 -10,480.00
Mar 31, 2023 11,442.00
Dec 31, 2022 -282.00
Sep 30, 2022 310.00
Jun 30, 2022 -233.00
Mar 31, 2022 351.00
Dec 31, 2021 385.00
Sep 30, 2021 -307.00
Jun 30, 2021 614.00
Mar 31, 2021 383.00